Medical Strategy is a portfolio manager specializing in investments in companies in the healthcare sector. The particular objective is to identify innovations in the healthcare sector at an early stage and to achieve long-term above-average results for investors by investing in low-valued growth companies. Our team continuously analyzes and tracks listed companies in all relevant investment segments of the healthcare sector. A particular focus is on smaller, as yet undiscovered biotechnology stocks. After all, it is these small and medium-sized companies that develop the groundbreaking therapies of tomorrow.
~ 900 companies
Development status, patents, competition, financial parameters.
A highly event-driven industry demands systemic data analysis